Early intervention for newborns screened for cystic fibrosis

American Journal of Respiratory and Critical Care Medicine

Volumn 188, Issue 4, 2013, Pages 409-410

  Beydon, Nicole ^a   Robinson, Paul D ^b  

^a ARMAND TROUSSEAU HOSPITAL   (France)

^b CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

NITROGEN; SODIUM CHLORIDE;

COMPUTER ASSISTED TOMOGRAPHY; CONSENSUS DEVELOPMENT; CYSTIC FIBROSIS; DISEASE COURSE; DISEASE EXACERBATION; EARLY CHILDHOOD INTERVENTION; EARLY DIAGNOSIS; EDITORIAL; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; HUMAN; LUNG CLEARANCE; LUNG FUNCTION; LUNG INJURY; MASS SPECTROMETRY; MEDICAL SOCIETY; NEWBORN SCREENING; PLETHYSMOGRAPHY; PRIORITY JOURNAL; RADIATION EXPOSURE; RELIABILITY; RESPIRATORY TRACT INFECTION; SEDATION; SEX RATIO;

BREATH TESTS; CYSTIC FIBROSIS; FEMALE; HUMANS; MALE; SALINE SOLUTION, HYPERTONIC;

EID: 84882715662     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201306-1023ED     Document Type: Editorial

References (17)

1. Borowitz D, Robinson KA, Rosenfeld M, Davis SD, Sabadosa KA, Spear SL, Michel SH, Parad RB, White TB, Farrell PM, et al.; Cystic Fibrosis Foundation. Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis. J Pediatr 2009; 155(6, Suppl): S73-S93.
2. Castellani C, Southern KW, Brownlee K, Dankert Roelse J, Duff A, Farrell M, Mehta A, Munck A, Pollitt R, Sermet-Gaudelus I, et al. European best practice guidelines for cystic fibrosis neonatal screening. J Cyst Fibros 2009;8:153-173.
3. Sims EJ, Clark A, McCormick J, Mehta G, Connett G, Mehta A; United Kingdom Cystic Fibrosis Database Steering Committee. Cystic fibrosis diagnosed after 2 months of age leads to worse outcomes and requires more therapy. Pediatrics 2007;119:19-28.
4. Mott LS, Park J, Murray CP, Gangell CL, de Klerk NH, Robinson PJ, Robertson CF, Ranganathan SC, Sly PD, Stick SM; AREST CF. Progression of early structural lung disease in young children with cystic fibrosis assessed using CT. Thorax 2012;67:509-516.
5. Rosenfeld M, Ratjen F, Brumback L, Daniel S, Rowbotham R, McNamara S, Johnson R, Kronmal R, Davis SD; ISIS Study Group. Inhaled hypertonic saline in infants and children younger than 6 years with cystic fibrosis: the ISIS randomized controlled trial. JAMA 2012;307:2269-2277.
6. Byrnes CA, Vidmar S, Cheney JL, Carlin JB, Armstrong DS, Cooper PJ, Grimwood K, MoodieM, Robertson CF, Rosenfeld M, et al. Prospective evaluation of respiratory exacerbations in children with cystic fibrosis from newborn screening to 5 years of age. Thorax 2013;68:643-651.
7. Elkins MR, Robinson M, Rose BR, Harbour C, Moriarty CP, Marks GB, Belousova EG, Xuan W, Bye PT; National Hypertonic Saline in Cystic Fibrosis (NHSCF) Study Group. A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis.N Engl JMed 2006;354: 229-240.
8. Subbarao P, Stanojevic S, Brown M, Jensen R, Rosenfeld M, Davis S, Brumback L, Gustafsson P, Ratjen F. Lung clearance index as an outcome measure for clinical trials in young children with cystic fibrosis: a pilot study using inhaled hypertonic saline. Am J Respir Crit Care Med 2013;188:456-460.
9. Amin R, Subbarao P, Lou W, Jabar A, Balkovec S, Jensen R, Kerrigan S, Gustafsson P, Ratjen F. The effect of dornase alfa on ventilation inhomogeneity in patients with cystic fibrosis. Eur Respir J 2011;37: 806-812.
10. Amin R, Subbarao P, Jabar A, Balkovec S, Jensen R, Kerrigan S, Gustafsson P, Ratjen F. Hypertonic saline improves the LCI in paediatric patients with CF with normal lung function. Thorax 2010;65:379-383.
11. Lum S, Stocks J, Stanojevic S, Wade A, Robinson P, Gustafsson P, Brown M, Aurora P, Subbarao P, Hoo AF, et al. Age and height dependence of lung clearance index and functional residual capacity. Eur Respir J 2013; 41:1371-1377.
12. Houltz B, Green K, Lindblad A, Singer F, Robinson PD, Nielsen KG, Gustafsson P. Tidal nitrogen washout ventilation inhomogeneity indices in a reference population aged 7-70 years. Eur Respir J 2012;40:694s.
13. Robinson PD, Latzin P, Verbanck S, Hall GL, Horsley A, Gappa M, Thamrin C, Arets HG, Aurora P, Fuchs SI, et al. Consensus statement for inert gas washout measurement using multiple- and single- breath tests. Eur Respir J 2013;41:507-522.
14. Singer F, Houltz B, Latzin P, Robinson PD, Gustafsson PM. A realistic validation study of a new nitrogen multiple-breath washout system. PLoS ONE 2012;7:e36083.
15. Schibler A, Schneider M, Frey U, Kraemer R. Moment ratio analysis of multiple breath nitrogen washout in infants with lung disease. Eur Respir J 2000;15:1094-1101.
16. Stocks J, Modi N, Tepper R. Need for healthy control subjects when assessing lung function in infants with respiratory disease. Am J Respir Crit Care Med 2010;182:1340-1342.
17. Stick S, Tiddens H, Aurora P, Gustafsson P, Ranganathan S, Robinson P, Rosenfeld M, Sly P, Ratjen F. Early intervention studies in infants and preschool children with cystic fibrosis: are we ready? Eur Respir J (In press)